And So It Begins... FDA PRESS RELEASE The U.S. Food and Drug Administration (FDA) has approved four vaccines for use against the 2009 H1N1 influenza virus. The vaccines—made by CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited, and sanofi pasteur … [Read more...] about FDA Approves Vaccines for H1N1 Influenza Virus
Archives for September 2009
FDA Gifts Merck’s Garasil With Broader Market Access
FDA advisory panel recommends approval of Gardasil to prevent genital warts in young men Bonus Lobbying Victory: European regulators give Gardasil nod for use in women up to the age of 45 Last week was good to Merck's hopes for an improved bottom line next quarter. It was a … [Read more...] about FDA Gifts Merck’s Garasil With Broader Market Access
MERCK Press Release Touting Clinical Efficacy of Gardasil for Mature Women
The product information for Gardasil® has been updated to include the clinical efficacy and safety of the vaccine for women up to 45 years of age. - The product information of the four-type (6,11,16,18) human papillomavirus (HPV) vaccine Gardasil® has been updated to include the … [Read more...] about MERCK Press Release Touting Clinical Efficacy of Gardasil for Mature Women
Vical Pandemic Influenza Vaccine Shows Strong Results in H1N1 Study
Vical vax demonstrates cross-reactivity against California,Texas and Mexico H1N1 strains Vical Pandemic Influenza Vaccine Demonstrates Cross-reactivity Against California, Texas and Mexico H1N1 Strains Vical Incorporated (Nasdaq:VICL) announced today that the company's DNA … [Read more...] about Vical Pandemic Influenza Vaccine Shows Strong Results in H1N1 Study
Cervarix On Track for FDA Approval, Garasil to Have Expanded Use
FDA experts back Merck's application to extend the use of Gardasil to males In twin votes likely to add considerable force to U.S. marketing efforts for HPV vaccines, an FDA expert panel has voted to back GlaxoSmithKline's long delayed application to market its HPV vaccine … [Read more...] about Cervarix On Track for FDA Approval, Garasil to Have Expanded Use